Prager G, Wagner G
Dtsch Med Wochenschr. 1984 Dec 14;109(50):1914-7. doi: 10.1055/s-2008-1069478.
A beta-adrenoceptor antagonist, bisoprolol, was given by mouth, 5 and 10 mg doses per 24 hours, in a double-blind randomized cross-over trial to 12 patients with stable coronary-heart disease. Ischaemia criteria proved not reproducible in control ergometry tests on two patients, leaving ten patients for further evaluation. On two days, one week apart, bicycle ergometry was undertaken until the occurrence of ST segment depression of at least 0.3 mV, often associated with angina. Four, eight and 24 hours after the drug had been taken, the ergometry was repeated to the same maximal Watt level and duration of exercise. Heart rate and pressure-rate product at rest, as well as the same parameters including ST segment depressions immediately at the end of exercise, significantly fell after bisoprolol during the entire trial period independently of the dose. There was no sign of reduced effectiveness 24 hours after drug intake. The results indicate that treatment of stable angina with bisoprolol can be achieved with a single daily dose.
在一项双盲随机交叉试验中,对12例稳定型冠心病患者口服β-肾上腺素能受体拮抗剂比索洛尔,剂量为每24小时5毫克和10毫克。在两名患者的对照运动试验中,缺血标准被证明不可重复,因此剩下10名患者进行进一步评估。在相隔一周的两天内,进行自行车运动试验,直到出现至少0.3毫伏的ST段压低,这通常与心绞痛有关。服药后4小时、8小时和24小时,以相同的最大瓦特水平和运动持续时间重复进行运动试验。在整个试验期间,比索洛尔给药后,静息心率和压力-心率乘积以及运动结束时包括ST段压低在内的相同参数均显著下降,且与剂量无关。服药24小时后没有疗效降低的迹象。结果表明,比索洛尔治疗稳定型心绞痛每日单次给药即可。